Retraction
Molecular analysis of the effects of Piroxicam and Cisplatin on mesothelioma cells growth and viability
Paper Information
Record ID:
41523
Author(s):
Publication Date:
May 22, 2008
Retraction Date:
December 27, 2022
(2.9 years years ago)
Subjects:
Institutions:
- Laboratory D, Dept. for the Development of Therapeutic Programs, CRS, Regina Elena Cancer Institute, Via delle Messi d'Oro 156, 00158, Rome, Italy
- Department of General Pathology and Oncology, Centro Sperimentale S. Andrea delle Dame, Second University of Naples, Via Costantinopoli 16, 80138, Naples, Italy
- Department of Biochemistry and Biophysics, Section of Pathology, Second University of Naples, Via L. Armanni 5, 80138, Naples, Italy
- Campania Regional Operating Center (COR) of the National Mesothelioma Registry (ReNaM) and Department of Experimental Medicine, Second University of Naples, Via Costantinopoli 16, 80138, Naples, Italy
Country:
🇮🇹 ItalyArticle Type:
Publisher:
Springer - Biomed Central (BMC)
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1186/s12967-022-03834-5Additional Notes:
see also: https://pubpeer.com/publications/7E2C21811841DEE5C4C2AAD694A8CB
Citations (19)
19
Total Citations0
Post-Retraction19
Pre-Retraction0
Same DayRecent Advances in Synthesis and Medicinal Evaluation of 1,2‐Benzothiazine Analogues
Reetu Reetu, Raghuram Gujjarappa, Chandi C. Malakar
Asian Journal of Organic Chemistry
Published: May 2022
15 citations
15 citations
227 days before retraction
Box-Behnken design optimization and in vitro cell based evaluation of piroxicam loaded core-shell type hybrid nanocarriers for prostate cancer
Ceyda Tuba Şengel-Türk, Erva Özkan, Filiz Bakar‐Ates
Journal of Pharmaceutical and Biomedical Analysis
Published: Apr 2022
17 citations
17 citations
245 days before retraction
Uncovering drug repurposing candidates for head and neck cancers: insights from systematic pharmacogenomics data analysis
Annie Wai Yeeng Chai, Aik Choon Tan, Sok Ching Cheong
Scientific Reports
Open Access
Published: Dec 2021
9 citations
9 citations
378 days before retraction
NSAIDs: Old Acquaintance in the Pipeline for Cancer Treatment and Prevention─Structural Modulation, Mechanisms of Action, and Bright Future
Sandra Ramos-Inza, Ana Carolina Ruberte, Carmen Sanmartín et al. (5 authors)
Journal of Medicinal Chemistry
Published: Nov 2021
43 citations
43 citations
406 days before retraction
Anti-inflammatory and cytoprotective potentials of Meloxicam solid dispersions prepared by different techniques on lipopolysaccharide-stimulated RAW 264.7 macrophages
Nesrin F. Taha, Khaled Mahmoud, Ahmed A. F. Soliman et al. (4 authors)
Journal of Drug Delivery Science and Technology
Published: Mar 2021
11 citations
11 citations
636 days before retraction
Potential candidate treatment agents for targeting of cholangiocarcinoma identified by gene expression profile analysis
Suthipong Chujan, Tawit Suriyo, Teerapat Ungtrakul et al. (5 authors)
Biomedical Reports
Open Access
Published: May 2018
6 citations
6 citations
1680 days before retraction
Synthesis, spectroscopic and DFT structural characterization of two novel ruthenium(III) oxicam complexes. In vivo evaluation of anti-inflammatory and gastric damaging activities
Gabriella Tamasi, Caterina Bernini, Gianfranco Corbini et al. (9 authors)
Journal of Inorganic Biochemistry
Published: Jan 2014
26 citations
26 citations
3258 days before retraction
Mesothelioma and Hypoxia: Modulation of the Inflammation-Related Phenotype and Identification of Prognostic Markers
Irene Cardillo Gianfranca Curzio
Journal of Cancer Science & Therapy
Published: Jan 2014
4 citations
4 citations
3282 days before retraction
pH-responsive micelles composed of poly(ethylene glycol) and cholesterol-modified poly(monomethyl itaconate) as a nanocarrier for controlled and targeted release of piroxicam
Zhaleh Pourmoazzen, Massoumeh Bagheri, Ali Akbar Entezami et al. (4 authors)
Journal of Polymer Research
Published: Nov 2013
13 citations
13 citations
3326 days before retraction
Cytoprotective and enhanced anti-inflammatory activities of liposomal piroxicam formulation in lipopolysaccharide-stimulated RAW 264.7 macrophages
Muhammad Nazrul-Hakim, Yoke Keong Yong, Chiong et al. (7 authors)
International Journal of Nanomedicine
Open Access
Published: Mar 2013
36 citations
36 citations
3588 days before retraction
Enhanced Cisplatin Response with Histone Acetyl Transferase Inhibitor, Anacardic Acid, in Malignant Pleural Mesothelioma Cell Line
Hacer İlke Önen, Akın Yılmaz, Ebru Alp et al. (7 authors)
Turkiye Klinikleri Journal of Medical Sciences
Open Access
Published: Jan 2013
1 citation
1 citation
3647 days before retraction
MCF-7 Breast Cancer Cell Line, a Model for the Study of the Association Between Inflammation and ABCG2-Mediated Multi Drug Resistance
Fatemeh Kalalinia, Fatemeh Mosaffa, Javad Behrav
InTech eBooks
Open Access
Published: Dec 2011
1 citation
1 citation
4031 days before retraction
Apoptosis Induced by Piroxicam plus Cisplatin Combined Treatment Is Triggered by p21 in Mesothelioma
Alfonso Baldi, Maria Teresa Piccolo, Mariarosaria Boccellino et al. (13 authors)
PLoS ONE
Open Access
Published: Aug 2011
47 citations
47 citations
4150 days before retraction
Metal-Oxicam Coordination Compounds: Structure, Biological Activity and Strategies for Administration
Gabriella Tamasi
The Open Crystallography Journal
Published: Mar 2010
7 citations
7 citations
4660 days before retraction
Evaluation of indomethacin and dexamethasone effects on BCRP-mediated drug resistance in MCF-7 parental and resistant cell lines
Fatemeh Elahian, Fatemeh Kalalinia, Javad Behravan
Drug and Chemical Toxicology
Published: Mar 2010
26 citations
26 citations
4663 days before retraction
Synergistic effect of gefitinib and rofecoxib in mesothelioma cells
Daniela Stoppoloni, Claudia Canino, Irene Cardillo et al. (7 authors)
Molecular Cancer
Open Access
Published: Feb 2010
22 citations
22 citations
4711 days before retraction
COX-2 specific inhibitors enhance the cytotoxic effects of pemetrexed in mesothelioma cell lines
Sara L. O’Kane, Gina Eagle, John Greenman et al. (5 authors)
Lung Cancer
Published: May 2009
32 citations
32 citations
4971 days before retraction
Chemosensitivity in Malignant Mesothelioma; Future Strategy
Ji Young Park, S. Ogawa, Jang Chul Park et al. (9 authors)
Haigan
Open Access
Published: Jan 2009
5108 days before retraction
Expression of the embryonic lethal abnormal vision‐like protein HuR in human mesothelioma
Daniela Stoppoloni, Irene Cardillo, Alessandra Verdina et al. (9 authors)
Cancer
Published: Oct 2008
30 citations
30 citations
5199 days before retraction
Quick Stats
Total Citations:
19
Years Since Retraction:
2.9 years
Open Access:
Yes
Last Checked:
Jul 24, 2025